MREO Financial Facts

Total general an administrative expenses: 165.59K
(Loss) from operations: -144.23K
See Full Income Statement

Accrued expenses: 63.68K
Other current liabilities: 12K
See Full Balance Sheet

Mereo BioPharma Group plc (MREO) Earnings

  |   Expand Research on MREO
Next EPS Date 8/12/26 *Est. EPS Growth Rate +100.0% *Last Qtr.
Average EPS % Beat Rate -100.0% Revenue Growth Rate N/A
Average % Move 1-Wk after EPS +5.7% Normal Earnings Time Before Open
Date  Qtr EPS Cons. Surprise Revs Cons. Gd. 1-Week % 1-Day % Details
4/1/26 Q126 N/A-$0.01 N/A N/A$30M N/A N/A N/A
11/18/25 Q325 N/A$0.01 N/A N/A$17.5M N/A N/A N/A
8/12/25 Q225 -$0.02$0.00 -$0.02N/AN/A N/A Details
5/13/25 Q125 -$0.02$0.01 -$0.03N/A$26.88M N/A Details
3/26/25 Q424 N/A-$0.01 N/A N/A$36.25M N/A N/A N/A
11/12/24 Q324 -$0.02-$0.02 $0.00N/AN/A N/A Details
9/17/24 Q324 N/A-$0.01 N/A N/AN/A N/A N/A N/A
8/13/24 Q224 -$0.02-$0.01 -$0.01N/AN/A N/A Details